Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson’s Disease

Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson’s Disease

Lewy body diseases (LBD) including dementia with Lewy bodies (DLB) and Parkinson disease (PD) are characterized by alpha-synuclein pathology. DLB is difficult to diagnose and peripheral biomarkers are urgently needed. Therefore, we analyzed the expression of five alpha-synuclein gene (<i>SNCA&...

Full description

Bibliographic Details
Main Authors:	Laura Marsal-García, Aintzane Urbizu, Laura Arnaldo, Jaume Campdelacreu, Dolores Vilas, Lourdes Ispierto, Jordi Gascón-Bayarri, Ramón Reñé, Ramiro Álvarez, Katrin Beyer
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	International Journal of Molecular Sciences
Subjects:	alpha-synuclein SNCA transcript variants dementia with Lewy bodies Parkinson’s disease differential mRNA transcript expression peripheral biomarker
Online Access:	https://www.mdpi.com/1422-0067/22/2/725

Similar Items

Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease
by: Desiree A. Piper, et al.
Published: (2018-04-01)

Parkinson Hastalığı ve İlişkili Olduğu Genler
by: Yener Kurman
Published: (2018-01-01)

Epigenetics in Lewy Body Diseases: Impact on Gene Expression, Utility as a Biomarker, and Possibilities for Therapy
by: Aintzane Urbizu, et al.
Published: (2020-07-01)

The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease
by: Michael X. Henderson, et al.
Published: (2022-06-01)

Platelet miRNA Biosignature Discriminates between Dementia with Lewy Bodies and Alzheimer’s Disease
by: Ana Gámez-Valero, et al.
Published: (2021-09-01)

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
by: Angeliki Spathopoulou, et al.
Published: (2022-01-01)

Genetic Elements at the Alpha-Synuclein Locus
by: Jordan Prahl, et al.
Published: (2022-07-01)

Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation
by: Katharina Pieger, et al.
Published: (2022-08-01)

Molecular Behavior of α-Synuclein Is Associated with Membrane Transport, Lipid Metabolism, and Ubiquitin–Proteasome Pathways in Lewy Body Disease
by: Tomoya Kon, et al.
Published: (2024-02-01)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
by: David J. Koss, et al.
Published: (2022-07-01)

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
by: Couch Yvonne, et al.
Published: (2011-11-01)

Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson’s Disease Risk
by: Alix Booms, et al.
Published: (2021-10-01)

Effects of α-synuclein on axonal transport
by: Laura A. Volpicelli-Daley
Published: (2017-09-01)

Neuronal-type-specific epigenome editing to decrease SNCA expression: Implications for precision medicine in synucleinopathies
by: Zhiguo Sun, et al.
Published: (2024-03-01)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
by: Hiroaki Sekiya, et al.
Published: (2022-09-01)

Skin alpha-synuclein deposit patterns: A predictor of Parkinson's disease subtypes
by: Yihang Han, et al.
Published: (2022-06-01)

Neuronal SNCA transcription during Lewy body formation
by: Tomoya Kon, et al.
Published: (2023-11-01)

Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression
by: Sara J. Fagen, et al.
Published: (2023-08-01)

Neuropathological evidence of body-first vs. brain-first Lewy body disease
by: Per Borghammer, et al.
Published: (2021-12-01)

Alpha-synuclein oligomers - neurotoxic molecules in Parkinson’s disease and other Lewy body disorders
by: Martin Ingelsson
Published: (2016-09-01)

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
by: Nelson de Oliveira Manzanza, et al.
Published: (2021-06-01)

Investigating the Pathogenic Interplay of Alpha-Synuclein, Tau, and Amyloid Beta in Lewy Body Dementia: Insights from Viral-Mediated Overexpression in Transgenic Mouse Models
by: Melina J. Lim, et al.
Published: (2023-10-01)

Norovirus Intestinal Infection and Lewy Body Disease in an Older Patient with Acute Cognitive Impairment
by: Manuel Moreno-Valladares, et al.
Published: (2022-07-01)

Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson’s disease: a genetic association study
by: Kari Anne Bjørnarå, et al.
Published: (2018-02-01)

Synuclein Motor Dysfunction Composite Scale for the Discrimination of Dementia With Lewy Bodies From Alzheimer’s Disease
by: Ying-Tsung Chen, et al.
Published: (2022-05-01)

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
by: P.G. Foulds, et al.
Published: (2012-01-01)

Inflammation in dementia with Lewy bodies
by: Jay Amin, et al.
Published: (2022-06-01)

Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies
by: Christopher Hatton, et al.
Published: (2020-07-01)

Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers
by: Tomohiro Umeda, et al.
Published: (2021-08-01)

Lewy Body-Associated Proteins A-Synuclein (a-syn) as a Plasma-Based Biomarker for Parkinson’s Disease
by: Xuemiao Zhao, et al.
Published: (2022-05-01)

Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies
by: Connor Bargar, et al.
Published: (2021-04-01)

Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
by: Francesco De Nuccio, et al.
Published: (2023-02-01)

Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
by: Allison J. Schaser, et al.
Published: (2020-08-01)

Interaction of Alpha Synuclein and Microtubule Organization Is Linked to Impaired Neuritic Integrity in Parkinson’s Patient-Derived Neuronal Cells
by: Lukas Seebauer, et al.
Published: (2022-02-01)

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
by: Melek Firat Altay, et al.
Published: (2022-11-01)

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models
by: Michiyo Iba, et al.
Published: (2020-07-01)

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression
by: Zachary A. Sorrentino, et al.
Published: (2019-09-01)

α-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons
by: Jessica M. Froula, et al.
Published: (2018-05-01)

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice
by: Matthieu Lilamand, et al.
Published: (2022-11-01)

Transcriptome Analysis in a Mouse Model of Premature Aging of Dentate Gyrus: Rescue of Alpha-Synuclein Deficit by Virus-Driven Expression or by Running Restores the Defective Neurogenesis
by: Laura Micheli, et al.
Published: (2021-08-01)